The membership, priced at $2,500 annually, aims to synthesize fragmented health information—ranging from wearable data and medical histories to deep biological testing—into a single, longitudinal care plan. Unlike conventional concierge services, the model emphasizes continuous oversight by board-certified physicians who utilize in-house clinical AI to interpret complex data, including DNA methylation analysis and over 140 blood biomarkers.
In section Releases
SONATA Debuts Preventive Health Membership in Three Major US Cities
With the launch of a new doctor-led healthcare membership, SONATA is targeting the disconnect between modern diagnostic data and actionable clinical guidance. The platform, now active in New York, San Francisco, and Los Angeles, integrates whole-genome sequencing and proprietary AI to move beyond traditional, reactive medicine.
Co-founder and CEO Sagan Schultz notes that despite an abundance of personal health data, patients often struggle to translate information into preventative strategies. By combining genomic insights with ongoing physician-led monitoring, the company intends to shift the focus from population-based averages to individualized screening and treatment. The startup, backed by investors including Lux Capital and Box Group, is led by a team with backgrounds at companies like Linear, Ramp, and Flatiron Health, and plans to scale its operations beyond its three launch cities.
Comments (0)
No comments yet. Be the first!